Crystal Crop Protection IPO: The Case For and Against, in Its Own Words

Six things going well and six things that could go wrong, all from the company's own prospectus, each with its page.

Om Prakash Choudhary · 15 November 2026

Crystal Crop Protection makes crop protection products, natural crop solutions and hybrid seeds. Its IPO opens for bids on 18 November and closes on 20 November, at a price band of ₹259 to ₹272 a share.

You will hear plenty of views on this IPO, and see a grey market premium quoted every day. This article does something different. It sets out both sides using only what the company itself says in its Red Herring Prospectus (RHP), dated 12 November 2026. Every point gives the page, so you can check it yourself.

We do not say whether you should apply. That is your decision, and it should be made on the facts.

What the prospectus shows going well

  1. Sales up 41% in two years. Revenue from operations grew from ₹2,229.9 crore in 2023-24 to ₹3,152.0 crore in 2025-26 (p. 461).
  2. Profit growing faster than sales. Profit after tax rose from ₹87.2 crore to ₹144.9 crore over the same two years, up 66% (p. 461). EBITDA, profit before interest, tax and depreciation, more than doubled, from ₹209.1 crore to ₹456.2 crore (p. 556).
  3. Profits are turning into cash. Operations brought in cash in each of the last three years: ₹337.8 crore, ₹383.0 crore and ₹256.4 crore (p. 462). Over the three years that is about 2.8 times the profit reported.
  4. Customers are not paying more slowly. Money owed by customers grew only 4% over two years, while sales grew 41% (pp. 460–461).
  5. Debt at a manageable level, and set to fall. Borrowings were about 0.45 times shareholders' equity at March 2026 (pp. 529, 460), and most of the fresh money raised is earmarked to repay loans (pp. 159–160).
  6. Promoters committed, and the money watched. Promoters hold 80.19% of the shares before the issue, and none of them are pledged (p. 137). An independent agency, CRISIL Ratings, will monitor how the IPO money is used (p. 178).

What the prospectus says could go wrong

  1. Most of the new money repays debt, not growth. ₹270 crore of the ₹355 crore fresh issue, 76%, goes to repaying borrowings of the company and its subsidiary (pp. 159–160). Borrowings were ₹820 crore at March 2026, against operating cash flow of ₹256 crore that year (pp. 529, 462).
  2. The promoter is selling at many times his cost. About 22% of the issue is an offer for sale: Ankur Aggarwal is selling up to 37.03 lakh shares, at an average cost of ₹23.51 a share (RHP cover page; p. 97). At ₹272, that is about ₹101 crore, roughly 11.6 times his cost. That money goes to him, not the company.
  3. One strong quarter in a seasonal business. Profit in the three months to June 2026 was ₹135.8 crore, almost as much as the ₹144.9 crore for the whole of 2025-26 (p. 461). The company itself warns that, because of seasonal fluctuations, its results “may not be relied upon as indicators” of future performance (p. 34), so one quarter should not be multiplied by four. In the same quarter, borrowings rose to ₹952 crore and operating cash flow was only ₹43.5 crore (pp. 529, 462).
  4. The auditors qualified their opinion. For 2023-24, 2024-25 and 2025-26, the auditors qualified their opinion over a ₹16.3 crore insurance claim, booked in 2012-13, that the insurer rejected (p. 45). They also report a material weakness in the controls over how such claims are recognised (p. 458), and a ₹109.4 crore demand from the Directorate General of Foreign Trade (p. 451).
  5. Criminal cases and an investigation. The litigation summary lists 85 criminal cases against the company and 4 against its promoters or directors (p. 36). There is a CBI case with a linked Enforcement Directorate case, and ₹30.2 crore of the company's assets is attached (pp. 46, 612–613). Tax disputes total ₹128.6 crore (pp. 616, 621).
  6. Compliance gaps. Statutory dues such as provident fund and tax deductions were paid late 91 times in 2025-26, ₹6.04 crore in all (p. 60). Three core approvals are awaiting renewal: a groundwater clearance, a hazardous waste authorisation and a consent to operate (p. 631).
On price: at ₹272, the shares are valued at about 23.8 times the company's 2025-26 earnings per share of ₹11.43 (p. 183). Whether that is reasonable depends on which of the two lists above you think will matter more.

How to use this

Neither list is a verdict. A company can repay debt and grow, or it can find that the problems in the second list cost more than expected. The question for any investor is which story the numbers support, and at what price. Our full review sets out six points to read closely and eleven worth checking, each with the prospectus's own words and page.

Read the full Crystal Crop review, free

This article is for information and education only. It is not investment advice or a recommendation to buy, sell or apply for any security. All figures are from Crystal Crop Protection Limited's Red Herring Prospectus dated 12 November 2026; page numbers are those printed in the RHP. The valuation multiple and the promoter's gain are our own calculations from the RHP's figures. Please read the offer document carefully and consult a SEBI-registered adviser before investing.

Source

  • Crystal Crop Protection Limited, Red Herring Prospectus dated 12 November 2026, filed with SEBI and the stock exchanges
  • The full Crystal Crop review, Review DRHPs